Media stories about Merge Healthcare (NASDAQ:MRGE) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Merge Healthcare earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 45.755263168155 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
About Merge Healthcare
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company’s Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers.
Receive News & Ratings for Merge Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merge Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.